Dynavax Technologies (DVAX) Competitor Comparison
We are evaluating the key criteria listed to compare Dynavax Technologies (DVAX) against its competitors in the Biotechnology industry.
Market Capitalization
93 / 368Gross Profits
18 / 278Total Revenue
31 / 300EBITDA
19 / 337Free Cashflow
13 / 352Quick Ratio
47 / 357Earnings per Share
36 / 359Dividend yield
0 / 6Total Cash
38 / 358Performance 3 years
120 / 368Performance 5 years
61 / 368Performance 10 years
109 / 368Linearity 3 years
42 / 368Linearity 5 years
192 / 368Linearity 10 years
25 / 368Total Rank
8 / 368Dividend Rank
112 / 368Valuation Rank
111 / 368Piotroski Rank
9 / 368Muliplier Rank
113 / 368Earnings per Share - DVAX ranking 36 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.